相关实验视频

Updated: May 6, 2026

Assessment of Cardiac Morphological and Functional Changes in Mouse Model of Transverse Aortic Constriction by Echocardiographic Imaging

Assessment of Cardiac Morphological and Functional Changes in Mouse Model of Transverse Aortic Constriction by Echocardiographic Imaging

Published on: June 21, 2016

阻塞性多变性心肌病的形态异常:从四维计算机断层扫描和手术相关联的洞察力

Yuki Izumi¹, Shuichiro Takanashi², Mitsunobu Kitamura¹

¹Hypertrophic Cardiomyopathy Center, Sakakibara Heart Institute, Tokyo, Japan; Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan.

Journal of cardiology

|July 13, 2024

概括

超性心肌病 (HCM) 涉及到超越隔膜缩的复杂解剖学. 四维计算机断层扫描 (4D-CT) 为改善阻塞性HCM手术规划提供了详细的形态评估.

科学领域:

心脏病学心脏病学
医疗成像医学成像
遗传学是一个遗传学.

背景情况:

增高性心肌病变 (HCM) 是一种遗传性心脏病.
左心室外流管 (LVOT) 阻塞显著影响HCM症状和预后.
传统的理解侧重于隔膜缩,但现在已经认识到其他异常.

研究的目的:

突出全面形态学评估在阻塞性HCM中的重要性.
评估四维计算机断层扫描 (4D-CT) 在描述复杂的HCM解剖学中的作用.
为了证明4D-CT详细的发现如何指导隔膜缩小疗法.

主要方法:

对HCM形态学的最新证据的审查.
用于评估HCM异常结构的成像方式的比较.
4D-CT的应用,以详细评估中枢,乳头肌肉和肌肉束.
使用4D-CT在专门的HCM中心进行手术规划.

主要成果:

HCM涉及复杂的解剖变异,包括二手和乳头肌肉异常,以及基肌肉束.
四维计算机断层扫描为详细的形态评估提供了卓越的空间分辨率和多平面功能.
4D-CT能够精确评估心脏下狭窄和右心室外流通道阻塞.
详细的4D-CT评估有助于规划阻塞性HCM的手术纠正.

结论:

准确的形态评估对于阻塞性HCM中有效的隔膜缩小疗法至关重要.
四维计算机断层扫描是HCM详细解剖评估的一个有价值的工具.
综合4D-CT指导的手术规划可以改善阻塞性HCM患者的结果.

关键词:

阿皮卡-基底肌肉捆绑计算机断层扫描 (CT) 是一种计算机断层扫描.过度缩性心肌病变性是一种心脏病变.中心门的中心门.Septal 减小疗法是一种减小疗法.

更多相关视频

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Published on: October 28, 2020

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

相关概念视频

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...